Results: 6

Renal osteodystrophy and clinical outcomes: data from the Brazilian Registry of Bone Biopsies - REBRABO

J. bras. nefrol; 42 (2), 2020
ABSTRACT Introduction: Mineral and bone disorders (MBD) are major complications of chronic kidney disease (CKD)-related adverse outcomes. The Brazilian Registry of Bone Biopsy (REBRABO) is an electronic database that includes renal osteodystrophy (RO) data. We aimed to describe the epidemiological profi...

Safety and efficacy of intravesical alum for intractable hemorrhagic cystitis: a contemporary evaluation

Int. braz. j. urol; 42 (6), 2016
ABSTRACT Introduction: Hemorrhagic cystitis (HC) represents a challenging clinical entity. While various intravesical agents have been utilized in this setting, limited data exist regarding safety or efficacy. Herein, then, we evaluated the effectiveness and complications associated with intravesical al...

The spectrum of bone disease in 200 chronic hemodialysis patients: a correlation between clinical, biochemical and histologic findings

Säo Paulo med. j; 116 (5), 1998
Introduction: Renal osteodystrophy includes the complete range of mineral metabolism disordes that affect the skeleton in patients with chronic renal failure. Patients and Methods: 200 patients with end-stage renal disease and on dialysis were investigated regarding the clinical, biochemical and histolog...

Dosagem de alumínio no soro de indivíduos sadios e em pacientes com insuficiência renal crônica mantidos ou näo em tratamento dialítico
Serum aluminium measurement in healthy people and in patients with chronic kidney failure with or without dialysis

J. bras. nefrol; 20 (2), 1998
Este trabalho descreve um método para a quantificaçao de alumínio por espectrofotometria de absorçao atômica, com forno de grafite. Amostras de soro de indivíduos normais e de pacientes com insuficiência renal crônica com e sem tratamento dialítico foram analisadas com a finalidade de quantifica...

Efeito do aluminio em plaquetas humanas

O efeito do aluminio foi avaliado em plaquetas humanas de individuos clinicamente saudaveis atraves de estudos de agregacao, peroxidacao e fosforilacao de proteinas em residuo de tirosina com os inibidores plaquetarios "in vitro" (Trolox, AAS, NDGA, EDTA E DFO). Os resultados obtidos demonstraram que o a...